Lisa M Wu1,2, Nadia Kuprian3, Krista Herbert4, Ali Amidi5,6, Jane Austin7, Heiddis Valdimarsdottir2,8, Christine Rini9. 1. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States. 2. Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, United States. 3. Derner Institute of Advanced Psychological Studies, Adelphi University, Garden City, New York, United States. 4. Department of Psychology, Rowan University, Glassboro, New Jersey, United States. 5. Unit for Psychooncology and Health Psychology, Department of Psychology, Aarhus University, Aarhus, Denmark. 6. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. 7. Department of Psychology, William Paterson University, Wayne, New Jersey, United States. 8. Department of Psychology, Reykjavik University, Reykjavik, Iceland. 9. John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, United States.
Abstract
OBJECTIVE: Hematopoietic stem cell transplant (HSCT) survivors may show evidence of objective cognitive impairment; however, perceived cognitive problems and their impact on quality of life are less well-understood. The purpose of this study was to explore HSCT survivors' perceptions of cognitive impairment and its effect on daily life functioning. METHOD: Sixty-nine autologous and allogeneic HSCT survivors nine months to three years posttransplant experiencing mild survivorship problems completed a brief structured interview regarding perceived cognitive impairment since transplant. Data were coded and content analyzed. The frequency of participants reporting cognitive problems by domain and associations between reports of cognitive problems and age, depressed mood, anxiety, and health-related quality of life were examined. RESULT: Overall, 49 of the 69 participants (71%) reported cognitive impairments after transplant: 38 in memory (55%), 29 in attention and concentration (42%), and smaller numbers in other domains. There were no significant differences in problems reported by transplant type. Of the 50 participants who worked before transplant, 19 (38%) did not return to work following transplant, with 12 citing cognitive and health problems as being the reason. There were significant associations between reports of cognitive impairment and younger age (p = 0.02), depressed mood (p = 0.02), anxiety (p = 0.002), and health-related quality of life (p = 0.008). SIGNIFICANCE OF RESULTS: A large proportion of survivors reported cognitive impairment following HSCT that impaired daily life functioning. Perceived cognitive impairment was associated with younger age, greater distress and reduced health-related quality of life.
OBJECTIVE: Hematopoietic stem cell transplant (HSCT) survivors may show evidence of objective cognitive impairment; however, perceived cognitive problems and their impact on quality of life are less well-understood. The purpose of this study was to explore HSCT survivors' perceptions of cognitive impairment and its effect on daily life functioning. METHOD: Sixty-nine autologous and allogeneic HSCT survivors nine months to three years posttransplant experiencing mild survivorship problems completed a brief structured interview regarding perceived cognitive impairment since transplant. Data were coded and content analyzed. The frequency of participants reporting cognitive problems by domain and associations between reports of cognitive problems and age, depressed mood, anxiety, and health-related quality of life were examined. RESULT: Overall, 49 of the 69 participants (71%) reported cognitive impairments after transplant: 38 in memory (55%), 29 in attention and concentration (42%), and smaller numbers in other domains. There were no significant differences in problems reported by transplant type. Of the 50 participants who worked before transplant, 19 (38%) did not return to work following transplant, with 12 citing cognitive and health problems as being the reason. There were significant associations between reports of cognitive impairment and younger age (p = 0.02), depressed mood (p = 0.02), anxiety (p = 0.002), and health-related quality of life (p = 0.008). SIGNIFICANCE OF RESULTS: A large proportion of survivors reported cognitive impairment following HSCT that impaired daily life functioning. Perceived cognitive impairment was associated with younger age, greater distress and reduced health-related quality of life.
Entities:
Keywords:
Cancer survivors; cancer-related cognitive impairment; cognitive dysfunction; hematopoietic stem cell transplantation; qualitative research; quality of life
Authors: Christine Rini; Jane Austin; Lisa M Wu; Gary Winkel; Heiddis Valdimarsdottir; Annette L Stanton; Luis Isola; Scott Rowley; William H Redd Journal: Health Psychol Date: 2013-11-25 Impact factor: 4.267
Authors: Saskia F A Duijts; Allard J van der Beek; Ingrid G Boelhouwer; Sanne B Schagen Journal: Curr Opin Support Palliat Care Date: 2017-03 Impact factor: 2.302
Authors: Debra Lynch Kelly; David Buchbinder; Rafael F Duarte; Jeffrey J Auletta; Neel Bhatt; Michael Byrne; Zachariah DeFilipp; Melissa Gabriel; Anuj Mahindra; Maxim Norkin; Helene Schoemans; Ami J Shah; Ibrahim Ahmed; Yoshiko Atsuta; Grzegorz W Basak; Sara Beattie; Sita Bhella; Christopher Bredeson; Nancy Bunin; Jignesh Dalal; Andrew Daly; James Gajewski; Robert Peter Gale; John Galvin; Mehdi Hamadani; Robert J Hayashi; Kehinde Adekola; Jason Law; Catherine J Lee; Jane Liesveld; Adriana K Malone; Arnon Nagler; Seema Naik; Taiga Nishihori; Susan K Parsons; Angela Scherwath; Hannah-Lise Schofield; Robert Soiffer; Jeff Szer; Ida Twist; Anne Warwick; Baldeep M Wirk; Jean Yi; Minoo Battiwalla; Mary E Flowers; Bipin Savani; Bronwen E Shaw Journal: Biol Blood Marrow Transplant Date: 2017-09-20 Impact factor: 5.742
Authors: Melissa A Friedman; Mercedes Fernandez; Jeffrey S Wefel; Katherine A Myszka; Richard E Champlin; Christina A Meyers Journal: Arch Clin Neuropsychol Date: 2009-09-18 Impact factor: 2.813
Authors: Patricia A Ganz; J E Bower; L Kwan; S A Castellon; D H S Silverman; C Geist; E C Breen; M R Irwin; S W Cole Journal: Brain Behav Immun Date: 2012-08-03 Impact factor: 7.217
Authors: Angela Scherwath; Lena Schirmer; Margitta Kruse; Gundula Ernst; Matthias Eder; Andreas Dinkel; Sabine Kunze; Friedrich Balck; Martin Bornhäuser; Gerhard Ehninger; Karin Dolan; Martin Gramatzki; Hans-Jochem Kolb; Pia Heußner; Hans Wilhelm; Dietrich W Beelen; Frank Schulz-Kindermann; Axel R Zander; Uwe Koch; Anja Mehnert Journal: Psychooncology Date: 2012-09-04 Impact factor: 3.894
Authors: Anna Barata; Aasha I Hoogland; Anuhya Kommalapati; Jennifer Logue; Taylor Welniak; Kelly A Hyland; Sarah L Eisel; Brent J Small; Reena V Jayani; Margaret Booth-Jones; Laura B Oswald; Brian D Gonzalez; Kedar S Kirtane; Michael D Jain; Sepideh Mokhtari; Julio C Chavez; Aleksandr Lazaryan; Bijal D Shah; Frederick L Locke; Heather S L Jim Journal: Transplant Cell Ther Date: 2022-05-14
Authors: Samantha J Mayo; Sean B Rourke; Eshetu G Atenafu; Rita Vitorino; Christine Chen; John Kuruvilla Journal: Pilot Feasibility Stud Date: 2021-01-30